A multicenter phase I trial of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814 in patients with solid tumors.

被引：6
|
作者：
van Bussel, Mark
Mau-Soerensen, Morten
Damstrup, Lars
Nielsen, Dorte
Verheul, Henk M. W.
Aftimos, Philippe Georges
De Jonge, Maja J.
Berghoff, Karin
Schellens, Jan H. M.
机构：
[1] Netherlands Canc Inst NKI, Amsterdam, Netherlands
[2] Rigshosp, Dept Oncol, Copenhagen, Denmark
[3] Merck KGaA, Darmstadt, Germany
[4] Herlev Hosp, Dept Oncol, Herlev, Denmark
[5] Canc Ctr, Dept Med Oncol, Amsterdam, Netherlands
[6] Inst Jules Bordet, Brussels, Belgium
[7] Erasmus MC, Canc Inst, Rotterdam, Netherlands
[8] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2556
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives
    Clapham, Kate M.
    Rennison, Tommy
    Jones, Gavin
    Craven, Faye
    Bardos, Julia
    Golding, Bernard T.
    Griffin, Roger J.
    Haggerty, Karen
    Hardcastle, Ian R.
    Thommes, Pia
    Ting, Attilla
    Cano, Celine
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (33) : 6747 - 6757
  • [32] Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
    Boucher, D.
    Hillier, S.
    Newsome, D.
    Wang, Y.
    Takemoto, D.
    Gu, Y.
    Markland, W.
    Hoover, R.
    Arimoto, R.
    Maxwell, J.
    Fields, S. Z.
    Charifson, P.
    Penney, M. S.
    Tanner, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Development of potent water-soluble inhibitors of the DNA-dependent protein kinase (DNA-PK)
    Cano, C.
    Curtin, N. J.
    Golding, B. T.
    Haggerty, K.
    Hardcastle, I. R.
    Hummersone, M.
    Menear, K.
    Richardson, C.
    Smith, G. C. M.
    Griffin, R. J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 41 - 42
  • [34] 8-biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
    Murr, Marine Desage-El
    Cano, Celine
    Golding, Bernard T.
    Hardcastle, Ian R.
    Hummersome, Marc
    Frigerio, Mark
    Curtin, Nicola J.
    Menear, Keith
    Richardson, Caroline
    Smith, Graeme C. M.
    Griffin, Roger J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4885 - 4890
  • [35] Heat sensitivity of double-stranded DNA-dependent protein kinase (DNA-PK) activity
    Ihara, M
    Suwa, A
    Komatsu, K
    Shimasaki, T
    Okaichi, K
    Hendrickson, EA
    Okumura, Y
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1999, 75 (02) : 253 - 258
  • [36] A novel, selective inhibitor of DNA-dependent protein kinase (DNA-PK) potentiates the effects of DNA-damaging therapies in hepatocellular carcinoma
    Willoughby, Catherine E.
    Thomas, Huw D.
    Rennison, Tommy
    Cano, Celine
    Reeves, Helen L.
    Wedge, Stephen R.
    CANCER RESEARCH, 2017, 77
  • [37] TP53 status determines the fate of cancer cells exposed to ionizing radiation and DNA-PK inhibitor, M3814
    Sun, Qing
    Guo, Yige
    Liu, Xiaohong
    Czauderna, Frank
    Zenke, Frank
    Blaukat, Andree
    Vassilev, Lyubomir T.
    CANCER RESEARCH, 2018, 78 (13)
  • [38] IDENTIFICATION AND CLONING OF DNA-SEQUENCES THAT BIND AND ACTIVATE THE DNA-DEPENDENT PROTEIN-KINASE (DNA-PK)
    MALIK, NP
    POLTORATSKY, V
    VANCUROVA, I
    CARTER, TH
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 301 - 301
  • [39] BINDING OF KU-DEPENDENT AND DNA-DEPENDENT PROTEIN-KINASE (DNA-PK) TO A NOVEL CHROMOSOMAL RECEPTOR
    SATOH, M
    AJMANI, AK
    REEVES, WH
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S72 - S72
  • [40] DNA ligase I activation during repair of alkylation damaged DNA is via DNA-dependent protein kinase (DNA-PK) mediated phosphorylation
    Bhat, KR
    Benton, BJ
    Ray, R
    FASEB JOURNAL, 1999, 13 (07): : A1453 - A1453
12345